Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

33.11
+0.93002.89%
Volume:511.22K
Turnover:16.84M
Market Cap:3.52B
PE:40.38
High:33.20
Open:32.41
Low:32.23
Close:32.18
52wk High:117.33
52wk Low:28.66
Shares:106.37M
Float Shares:86.88M
Volume Ratio:0.61
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8200
EPS(LYR):0.8200
ROE:15.01%
ROA:3.34%
PB:5.44
PE(LYR):40.38

Loading ...

Class action lawsuit targets Corcept Therapeutics over alleged securities law violations

Reuters
·
45 mins ago

Wolf Haldenstein files securities class action against Corcept Therapeutics over relacorilant statements

Reuters
·
Mar 16

Corcept Therapeutics (CORT) Is Down 5.1% After FDA Relacorilant Rejection And Investor Lawsuits - What's Changed

Simply Wall St.
·
Mar 15

Corcept Chief Development Officer William Guyer Disposes of Common Shares

Reuters
·
Mar 07

Corcept Investors Face April 21 Lead Plaintiff Deadline in Securities Fraud Class Action

Reuters
·
Mar 06

Hagens Berman Files Securities Class Action Against Corcept Therapeutics

Reuters
·
Mar 05

Canaccord Genuity Sticks to Its Buy Rating for Corcept Therapeutics (CORT)

TIPRANKS
·
Mar 04

Pomerantz Files Class Action Lawsuit Against Corcept Therapeutics

Reuters
·
Mar 04

Stock Track | Corcept Therapeutics Plummets 5.06% Intraday Following Securities Fraud Class Action Filing

Stock Track
·
Mar 04

Rosen Law Firm Files Securities Class Action Against Corcept Therapeutics

Reuters
·
Mar 03

Rosen Law Firm Urges Corcept Investors to Seek Counsel Before April 21 Lead Plaintiff Deadline

Reuters
·
Feb 28

Portnoy Law Firm Files Class Action Against Corcept Therapeutics

Reuters
·
Feb 27

Robbins LLP Alerts Corcept Investors to Lead Plaintiff Deadline in Class Action Lawsuit

Reuters
·
Feb 26

Lead Plaintiff Deadline Set in Corcept Therapeutics Securities Class Action

Reuters
·
Feb 26

Stock Track | Corcept Therapeutics Plummets 5.15% Intraday Following Analyst Price Target Cuts

Stock Track
·
Feb 26

Corcept Therapeutics Inc : Piper Sandler Cuts Target Price to $73 From $121

THOMSON REUTERS
·
Feb 25

Corcept Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 25

Corcept Therapeutics price target lowered to $60 from $67 at H.C. Wainwright

TIPRANKS
·
Feb 25

Corcept Therapeutics Inc. : H.c. Wainwright Cuts Target Price to $60 From $67

THOMSON REUTERS
·
Feb 25

U.S. RESEARCH ROUNDUP-Chevron, GoDaddy, HP

Reuters
·
Feb 25